Filter News
Area of Research
News Topics
- (-) Advanced Reactors (5)
- (-) Biomedical (2)
- 3-D Printing/Advanced Manufacturing (14)
- Artificial Intelligence (2)
- Bioenergy (6)
- Biotechnology (1)
- Clean Water (2)
- Computer Science (6)
- Coronavirus (6)
- Cybersecurity (1)
- Energy Storage (8)
- Environment (8)
- Fusion (5)
- Grid (4)
- Isotopes (1)
- Materials Science (4)
- Mathematics (1)
- Mercury (1)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (1)
- Nuclear Energy (13)
- Physics (1)
- Quantum Science (1)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (4)
- Transformational Challenge Reactor (2)
- Transportation (8)
Media Contacts
The Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new advanced technologies, could be operational by 2024.
As CASL ends and transitions to VERA Users Group, ORNL looks at the history of the program and its impact on the nuclear industry.
Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
A software package, 10 years in the making, that can predict the behavior of nuclear reactors’ cores with stunning accuracy has been licensed commercially for the first time.
Ask Tyler Gerczak to find a negative in working at the Department of Energy’s Oak Ridge National Laboratory, and his only complaint is the summer weather. It is not as forgiving as the summers in Pulaski, Wisconsin, his hometown.
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.